Sun Pharma Advanced Research Company informs about press release

14 May 2021 Evaluate

Pursuant to regulation 30 of the SEBI (Listing Obligation & Disclosure Requirements) Regulations, 2015, Sun Pharma Advanced Research Company has informed that it has enclosed the Press Release on 14th May 2021 titled ‘SPARC Announces Positive Top-line Results from Pivotal Phase 3 Clinical Trial of PDP-716 for the Treatment of Open Angle Glaucoma or Ocular Hypertension’ which is self-explanatory.

The above information is a part of company’s filings submitted to BSE.

Sun Pharma Adv. Res Share Price

133.75 -0.30 (-0.22%)
29-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Syngene Internation. 654.25
Indegene 522.50
CMS Info Systems 343.20
Sagility 52.23
Smartworks Coworking 472.85
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×